Endometrial brush cytology in the surveillance of post-menopausal patients under tamoxifen: A prospective longitudinal study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 132, Issue 1, 2007, Pages 126-128

  Mathelin, Carole ^a   Youssef, Cherif ^a   Annane, Kadour ^a   Brettes, Jean Philippe ^a   Bellocq, Jean Pierre ^b   Walter, Paul ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Breast cancer; Endometrial cancer; Endometrial cytology; Tamoxifen

Indexed keywords

TAMOXIFEN;

ARTICLE; CURETTAGE; ECHOGRAPHY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; FEMALE; HEALTH SURVEY; HUMAN; HYSTEROSCOPY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE;

EID: 34247336511     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.04.023     Document Type: Article

References (19)

1. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351 9114 (1998) 1451-1467
2. Deligdisch L., Kalir T., Cohen C.J., de Latour M., Le Bouedec G., and Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 78 2 (2000) 181-186
3. Bernstein L., Deapen D., Cerhan J.R., et al. Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91 19 (1999) 1654-1662
4. Kloos I., Delaloge S., Pautier P., et al. Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature. Int J Gynecol Cancer 12 5 (2002) 496-500
5. Lhomme C., Pautier P., Zagame L., et al. Endometrial surveillance of women on tamoxifen. Gynecol Obstet Fertil 31 7-8 (2003) 647-656
6. Suh-Burgmann E.J., and Goodmann A. Surveillance for endometrial cancer in women receiving tamoxifen. Ann Intern Med 131 (1999) 127-135
7. Fung M.F., Reid A., Faught W., et al. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen. Gynecol Oncol 91 1 (2003) 154-159
8. Koss L.G. Detection of endometrial carcinoma in asymptomatic peri- and postmenopausal women. Acta Cytol 24 (1980) 492-493
9. Mourits M.J., De vries E.G., Willemse P.H., Ten Hoor K.A., Hollema H., and Van der Zee A.G. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97 5 Pt 2 (2001) 855-866
10. Rieck G.C., Freites O.N., and Williams S. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer. J Obstet Gynaecol 25 January (1) (2005) 39-41
11. Love C.D., Muir B.B., Scrimgeour J.B., Leonard R.C., Dillon P., and Dixon J.M. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 17 7 (1999) 2050-2054
12. Barakat R.R., Gilewski T.A., Almadrones L., et al. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol 18 20 (2000) 3459-3463
13. Deckardt R., Lueken R.P., Gallinat A., et al. Comparison of transvaginal ultrasound, hysteroscopy, and dilatation and curettage in the diagnosis of abnormal vaginal bleeding and intrauterine pathology in perimenopausal and postmenopausal women. J Am Assoc Gynecol Laparosc 9 3 (2002) 277-282
14. MacKenzie I.Z., and Bibby J.G. Critical assessment of dilatation and curettage in 1029 women. Lancet 2 8089 (1978) 566-568
15. Mathelin C., Walter P., Gharbi M., Viville B., Gairard B., and Brettes JP. Is endometrial cytology of any use?. Proceedings of an international meeting. Brussels, Belgium, 12-13 December 1997. Eur J Cancer 34 4 (1998) 38-39
16. Kedar R.P., Bourne T.H., Powles T.J., et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343 8909 (1994) 1318-1321
17. Maksem J.A. Performance characteristics of the Indiana University Medical Center endometrial sampler (Tao Brush) in an outpatient office setting, first year's outcomes: recognizing histological patterns in cytology preparations of endometrial brushings. Diagn Cytopathol 22 3 (2000) 186-195
18. Del Priore G., Williams R., Harbatkin C.B., Wan L.S., Mittal K., and Yang G.C. Endometrial brush biopsy for the diagnosis of endometrial cancer. J Reprod Med 46 5 (2001) 439-443
19. Wu H.H., Harshbarger K.E., Berner H.W., and Elsheikh T.M. Endometrial brush biopsy (Tao brush). Histologic diagnosis of 200 cases with complementary cytology: an accurate sampling technique for the detection of endometrial abnormalities. Am J Clin Pathol 114 3 (2000) 412-418